semaglutide masld Improves Histology in MASH: Phase 3 ESSENCE Trial 🚨Beyond Journal Club: MASLD🚨 Fatty

Severe gastrointestinal disorders (symptomatic gastroparesis) affecting drug absorption or tolerance

Incorporate Healthy Fats Monounsaturated fats and omega-3 fatty acids increase GLP-1 secretion and slow stomach emptying

Checkpoint inhibitor medications function by targeting and inhibiting these regulatory pathways, specifically the interactions between checkpoint proteins and their ligands

Mass spectrometry: Confirms molecular mass (monoisotopic/average) and screens for truncations/modifications

Repeat TTE prior to surgery demonstrated a large apical and inferolateral pseudoaneurysm

Slowed Gastric Emptying Food moves through the digestive system at a controlled pace, but for some, it moves too quickly, leading to frequent hunger